Correlation Between Seres Therapeutics and Pieris Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Pieris Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Pieris Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Pieris Pharmaceuticals, you can compare the effects of market volatilities on Seres Therapeutics and Pieris Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Pieris Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Pieris Pharmaceuticals.
Diversification Opportunities for Seres Therapeutics and Pieris Pharmaceuticals
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Seres and Pieris is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Pieris Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pieris Pharmaceuticals and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Pieris Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pieris Pharmaceuticals has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Pieris Pharmaceuticals go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Pieris Pharmaceuticals
Given the investment horizon of 90 days Seres Therapeutics is expected to under-perform the Pieris Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Seres Therapeutics is 1.04 times less risky than Pieris Pharmaceuticals. The stock trades about -0.03 of its potential returns per unit of risk. The Pieris Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 7,912 in Pieris Pharmaceuticals on August 26, 2024 and sell it today you would lose (6,235) from holding Pieris Pharmaceuticals or give up 78.8% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Pieris Pharmaceuticals
Performance |
| Timeline |
| Seres Therapeutics |
| Pieris Pharmaceuticals |
Seres Therapeutics and Pieris Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Pieris Pharmaceuticals
The main advantage of trading using opposite Seres Therapeutics and Pieris Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Pieris Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pieris Pharmaceuticals will offset losses from the drop in Pieris Pharmaceuticals' long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| Pieris Pharmaceuticals vs. Adaptimmune Therapeutics Plc | Pieris Pharmaceuticals vs. Mereo BioPharma Group | Pieris Pharmaceuticals vs. PDS Biotechnology Corp | Pieris Pharmaceuticals vs. Leap Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |